Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Nakamura

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Acta Medica Okayama|June 24, 2015
Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary CirrhosisHiroyuki Seki, Fusao Ikeda, Shintaro Nanba, et al.
Disease Markers|March 21, 2014
STAT4 gene polymorphisms are associated with susceptibility and ANA status in primary biliary cirrhosisSatoru Joshita, Takeji Umemura, Minoru Nakamura, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 2009
Serum BAFF and APRIL levels in patients with PBCKiyoshi Migita, Bibigul Ilyassova, Elena F Kovzel, et al.
Scientific Reports|February 26, 2021
rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitisYuki Hitomi, Yoshihiro Aiba, Yosuke Kawai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 1, 2012
Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liverSung Kwan Bae, Hiroshi Yatsuhashi, Satoru Hashimoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 13, 2007
Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosisMinoru Nakamura, Atsumasa Komori, Masahiro Ito, et al.
Plos One|September 30, 2016
Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free TreatmentSatoru Hashimoto, Hiroshi Yatsuhashi, Seigo Abiru, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2006
Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathwaysTerufumi Yokoyama, Atsumasa Komori, Minoru Nakamura, et al.
Bioorganic & Medicinal Chemistry|February 21, 2018
Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonistsTakuto Kojima, Michiyo Mochizuki, Takafumi Takai, et al.
The Journal of Rheumatology|August 17, 2011
Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synoviumKiyoshi Migita, Tomohiro Koga, Atsumasa Komori, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Acta Medica Okayama|June 24, 2015
Aberrant Expression of Keratin 7 in Hepatocytes as a Predictive Marker of Rapid Progression to Hepatic Failure in Asymptomatic Primary Biliary CirrhosisHiroyuki Seki, Fusao Ikeda, Shintaro Nanba, et al.
Disease Markers|March 21, 2014
STAT4 gene polymorphisms are associated with susceptibility and ANA status in primary biliary cirrhosisSatoru Joshita, Takeji Umemura, Minoru Nakamura, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 2009
Serum BAFF and APRIL levels in patients with PBCKiyoshi Migita, Bibigul Ilyassova, Elena F Kovzel, et al.
Scientific Reports|February 26, 2021
rs1944919 on chromosome 11q23.1 and its effector genes COLCA1/COLCA2 confer susceptibility to primary biliary cholangitisYuki Hitomi, Yoshihiro Aiba, Yosuke Kawai, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 1, 2012
Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liverSung Kwan Bae, Hiroshi Yatsuhashi, Satoru Hashimoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 13, 2007
Predictive role of anti-gp210 and anticentromere antibodies in long-term outcome of primary biliary cirrhosisMinoru Nakamura, Atsumasa Komori, Masahiro Ito, et al.
Plos One|September 30, 2016
Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free TreatmentSatoru Hashimoto, Hiroshi Yatsuhashi, Seigo Abiru, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 25, 2006
Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathwaysTerufumi Yokoyama, Atsumasa Komori, Minoru Nakamura, et al.
Bioorganic & Medicinal Chemistry|February 21, 2018
Discovery of 1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazoles as novel class of corticotropin releasing factor 1 receptor antagonistsTakuto Kojima, Michiyo Mochizuki, Takafumi Takai, et al.
The Journal of Rheumatology|August 17, 2011
Influence of Janus kinase inhibition on interleukin 6-mediated induction of acute-phase serum amyloid A in rheumatoid synoviumKiyoshi Migita, Tomohiro Koga, Atsumasa Komori, et al.
Pageof 15